Eli Lilly (LLY) vs Johnson & Johnson (JNJ)
Eli Lilly (LLY) and Johnson & Johnson (JNJ) side by side: both in Healthcare, both listed on New York Stock Exchange. Eli Lilly is the larger of the two by approximate market capitalization (about 1.7×).
| Field | Eli Lilly | Johnson & Johnson |
|---|---|---|
| Legal name | Eli Lilly and Company | Johnson & Johnson |
| Ticker | LLY | JNJ |
| Exchange | New York Stock Exchange XNYS | New York Stock Exchange XNYS |
| Jurisdiction | United States | United States |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharma & MedTech |
| Market cap ≈ | $1.1tn | $645.9bn |
| Founded | 1876 | 1886 |
| Reporting currency | USD | USD |
| LEI | FRDRIPF3EKNDJ2CQJL29 | 549300G0CFPGEF6X2043 |
| ISIN | US5324571083 | US4781601046 |
| FIGI | BBG001S5STL8 | BBG001S5SHQ9 |
| Index membership | S&P 500 | S&P 500 |
| Held by (covered funds) | 1 | — |
Eli Lilly
Pharmaceutical maker; GLP-1 metabolic drugs (Mounjaro, Zepbound), oncology and neuroscience.
What they share
Same indices: S&P 500
Market caps are computed from each issuer's own filed share count times the close on 2026-08-28, not copied from a vendor; LEI from GLEIF (CC0), ISIN read from each issuer's own primary listing document with its ISO 6166 check digit validated, FIGI from OpenFIGI, MIC from the ISO 10383 registry — full provenance on Sources. Not real-time, not investment advice. Both sides as data: /api/v1/companies/eli-lilly · /api/v1/companies/johnson-johnson